Clinical Trial Update: Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating neoadjuvant weekly paclitaxel in breast cancer with biomarkers of therapy response; recruitment is ongoing and prior re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Breast Neoplasm Female | Phase 4 | Status: RECRUITING | Results posted: 2023-10-13